Log In
Print
BCIQ
Print
Print this Print this
 

Arcapta Neohaler, Onbrez Breezhaler, Onbrez Inhalation Capsules, indacaterol (QAB149)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionLong-acting adrenergic receptor beta 2 agonist (LABA)
Molecular Target Adrenergic receptor beta 2 (ADRB2)
Mechanism of ActionAdrenergic receptor beta 2 (ADRB2) agonist
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentMarketed
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat airflow obstruction in chronic obstructive pulmonary disease (COPD) patients; Treat chronic obstructive pulmonary disease (COPD); Treat mild to moderate chronic obstructive pulmonary disease (COPD); Treat moderate to severe chronic obstructive pulmonary disease (COPD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today